STAAR Surgical Company appointed David Bailey as Chief Commercial Officer, effective September 8, 2026. Mr. Bailey returns to the company he previously led as CEO from 2001 to 2008 and President of International Operations until 2011. His compensation includes an annual base salary of approximately $575,000, a target bonus of 60% of base, and equity grants valued at $850,000 in RSUs plus a $1,400,000 long-term incentive award split between options and RSUs. The appointment aims to accelerate revenue growth for the EVO ICL product line as laser refractive procedures decline globally. STAAR Surgical Company is a medical device manufacturer specializing in implantable phakic intraocular lenses for vision correction.
